Product Code: ETC13258949 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 | |
According to 6Wresearch internal database and industry insights, the Global Eczema Market was valued at USD 11.3 Billion in 2024 and is expected to reach USD 17.2 Billion by 2031, growing at a compound annual growth rate of 8.18% during the forecast period (2025-2031).
Global Eczema Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Eczema Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Eczema Market Revenues & Volume, 2021 & 2031F |
3.3 Global Eczema Market - Industry Life Cycle |
3.4 Global Eczema Market - Porter's Five Forces |
3.5 Global Eczema Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Eczema Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Global Eczema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Eczema Market Trends |
6 Global Eczema Market, 2021 - 2031 |
6.1 Global Eczema Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Eczema Market, Revenues & Volume, By Adbry (Tralokinumab), 2021 - 2031 |
6.1.3 Global Eczema Market, Revenues & Volume, By Elidel (Pimecrolimus topical), 2021 - 2031 |
6.1.4 Global Eczema Market, Revenues & Volume, By Dupixent (Dupilumab), 2021 - 2031 |
6.1.5 Global Eczema Market, Revenues & Volume, By Cibinqo (Abrocitinib), 2021 - 2031 |
6.1.6 Global Eczema Market, Revenues & Volume, By Rinvoq (Upadacitinib), 2021 - 2031 |
6.1.7 Global Eczema Market, Revenues & Volume, By ARQ252, 2021 - 2031 |
6.1.8 Global Eczema Market, Revenues & Volume, By Amlitelimab, 2021 - 2031 |
6.1.9 Global Eczema Market, Revenues & Volume, By Lebrikizumab, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.3.1 Overview & Analysis |
7 North America Eczema Market, Overview & Analysis |
7.1 North America Eczema Market Revenues & Volume, 2021 - 2031 |
7.2 North America Eczema Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Eczema Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Eczema Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Eczema Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Eczema Market, Revenues & Volume, By Drugs, 2021 - 2031 |
8 Latin America (LATAM) Eczema Market, Overview & Analysis |
8.1 Latin America (LATAM) Eczema Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Eczema Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Eczema Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Eczema Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Eczema Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Eczema Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Eczema Market, Revenues & Volume, By Drugs, 2021 - 2031 |
9 Asia Eczema Market, Overview & Analysis |
9.1 Asia Eczema Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Eczema Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Eczema Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Eczema Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Eczema Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Eczema Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Eczema Market, Revenues & Volume, By Drugs, 2021 - 2031 |
10 Africa Eczema Market, Overview & Analysis |
10.1 Africa Eczema Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Eczema Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Eczema Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Eczema Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Eczema Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Eczema Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Eczema Market, Revenues & Volume, By Drugs, 2021 - 2031 |
11 Europe Eczema Market, Overview & Analysis |
11.1 Europe Eczema Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Eczema Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Eczema Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Eczema Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Eczema Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Eczema Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Eczema Market, Revenues & Volume, By Drugs, 2021 - 2031 |
12 Middle East Eczema Market, Overview & Analysis |
12.1 Middle East Eczema Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Eczema Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Eczema Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Eczema Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Eczema Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Eczema Market, Revenues & Volume, By Drugs, 2021 - 2031 |
13 Global Eczema Market Key Performance Indicators |
14 Global Eczema Market - Export/Import By Countries Assessment |
15 Global Eczema Market - Opportunity Assessment |
15.1 Global Eczema Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Eczema Market Opportunity Assessment, By Drugs, 2021 & 2031F |
16 Global Eczema Market - Competitive Landscape |
16.1 Global Eczema Market Revenue Share, By Companies, 2024 |
16.2 Global Eczema Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |